Hypersscretion of ACTH growth hormone and prolactin in a patient with pituitary adenoma by Müller, O. A. et al.
mmmmi, Advance Abstracts 
23. Symposion 
Deutsche Gesellschaft für Endokrinologie 
Ulm, February 22-25,1978 
endocrino 
logica 
Supplementum 215 f 
ADVANCE ABSTRACTS OF SHORT PAPERS 
Programme Committee 
E. F. Pfeiffer, Chairman 
G. Bettendorf 
Μ. Breckwoldt 








with the assistance of Mrs. J. Kemmer 
and Miss E. Ryssel 
ISBN 87-7494-162-3 
ISSN 0300-9750 
Printed in Germany by Brühische Universitätsdruckerei, Lahn-Giessen 
G E R M A N SOCIETY OF E N D O C R I N O L O G Y 





Board members at large: 
Ε. F. Pfeiffer, Ulm 
P. W. Jungblut, Wilhelmshaven 
G. Bettendorf, Hamburg 
A. von zur Mühlen, Hannover 
D. Knorr, München 
R. Knuppen, Lübeck 
W. Wuttke, Göttingen 
Mailing address of the Society: D-3000 Hannover 61 
Karl-Wiechert-Allee 9 
c/o Prof. Dr. A. von zur Mühlen 
Medizinische Hochschule Hannover 
Dept. Innere Medizin 
Abt. Klinische Endokrinologie 
CONTENTS 
ABSTRACTS OF SHORT PAPERS 
(* denotes poster presentation) 
Page 
Pituitary, Prolactin, ST Η 
1. Κ. v. Werder, Μ. Gottsmann, C. Brendel, R. Landgraf, H. v. hieven, Η. K. Rjosk, R. 
Fahlbusch: Treatment of prolactinomas: Efficacy of radiotherapy 1 
2. Η. K. Rjosk, H. Huben Pregnancies in patients with prolactinomas 2 
3. W. Winkelmann, U. Fricke, W. Hadam, D. Heesen, R. Mies, E. Rausch: Influence of 
sulpiride on plasma prolactin in patients with pituitary tumors *) 3 
4. 0. A. Müller, R. Fink, K. v. Werder, P. C. Scriba: Hypersecretion of ACTH, growth 
hormone and prolactin in a patient with pituitary adenoma 4 
5. K.-D. Döhler, C. C. Wong, A. von zur Mühlen: Comparative effects of gonadal hormones 
on prolactin release in male and female rats *) 5 
6. H. G. Bohnet, E. del Pozo, F. Gomez: Control of mammary prolactin receptors in the 
female rat *) 7 
7. H. J. Quabbe, M. Gregor, C. Bumke-Vogt, A. Eckhof, P. Bohlscheid, Μ. Schoppenhorst: . 
24-th pattern of growth hormone, prolactin and Cortisol in the Rhesus monkey . . . 8 
8. G. Mayer, G Schwinn: Exercise-induced growth hormone release: Suppression by 
TRH and augmentation by bromocriptine 10 
9. G. Schwinn, B. Heckrodt, J. Köbberling: The effect of pimozide, TRH and cyproheptadine 
on sleep-induced growth hormone secretion in man 11 
10. L . Nocke-Finck, H. H. v. Burgsdorff, Η. Wassmann, Η. Breuer: Growth hormone and 
Cortisol in the plasma of patients with traumatic apallic syndrome *) 12 
11. J. Köbberling, C. Mcintosh, C. Blossey: Binding capacity and affinity of membrane-
bound hGH receptors from rabbit liver: Studies of age dependence, influence of hGH 
pretreatment and receptor stability 13 
12. G. Basiert, Κ. Η. Usadel, P. Η. Althoff: Function of human fetal pituitary transplants 
in nude mice 13 
ACTH, Adrenal Cortex 
13. G. Kummer, Κ. Ε. Beinert, R. Lang: Positive rate-sensitive steroid feedback mechanism 
of ACTH secretion in Cushing's disease 15 
14. H. L . Fehm, G. Kummer: Rate-sensitive feedback effects of glucocorticoids on ACTH 
hypersecretion in hypoadrenocorticism 16 
15. Κ. H. Voigt, Ε. Weber, D. Breitig, R. Martin: ACTH secretion of isolated pars intermedia 
cells from rat pituitaries *) 17 
16. R. Peters, M. Schleyer: Structure-activity relationship of corticosteroids on the 
inhibition of A C T H release from isolated pituitary cells 18 
17. H. Kling, R. Martin: Maintenance in monolayer culture of corticotropic cells separated 
by velocity sedimentation *) 19 
18. E. Weber, Κ. Η. Voigt: Ultrastructural characterization of ACTH producing cells of the 
rat anterior pituitary by electron microscopic immunocytochemistry *) 20 
19. B. Schefzig, M. Schöneshöf er: Short-term kinetics of serum concentrations of eight 
adrenal steroids and plasma A C T H after a single dose of metyrapone 21 
20. R. Fuchs-Hammoser, M. Schweiger, W Oelkers: Chronic low-dose ACTH stimulation 
of adrenocortical steroid secretion in man 22 
V I I 
Page 
21. Ο. Α. Müller, R. Fahlbusch: Differential therapy in patients with Cushing's disease . . 23 
22. Μ. Β. Oziol, C. Meissner, Ch. Herfarth: Corticosteroid production of isolated cells 
from human adrenocortical tumors 24 
23. C. Bernutz, K. Horn, C. R. Pickardt: Characterization of corticosteroid-binding globulin 
(CBG) and radioimmunological determination in human serum 25 
24. J. Homoki, W. M. Teller: Particularities of urinary steroid excretion in neonates and 
infants with C2l-hydroxylase deficiency *) 26 
25. R, Müller, Α. Scheuer, Η. Gerdes, K.-O. Mosebach: New antigens with steroids as the 
immunodeterminant group: Coupling of 5a-dihydrotesttosterone to bovine serum 
albumin by reductive amination *) 28 
26. Ch. Witting, E. J. Wickings, E. Nieschlag: Immune complex nephritis following active 
immunisation with steroid-protein conjugates *) 29 
27. R. Krüger, Ch. Hönbach, C. Meissner, G Dhom: Morphology and function of the 
transplantable adrenocortical carcinoma Snell 494 and the adrenal cortex of tumor-
bearing rats *) 30 
28. J. Veser, P. Geywitz, H. Thomas: Fluorometric localization of catechol-O-methyl-
transferase after electrophoresis in Polyacrylamide gel *) 31 
Androgens, Estrogens, Pregnancy 
29. A. Hecker, S. H. Hasan, F. Neumann: Effect of spironolactone on the sexual differentia-
tion of rat fetuses 32 
30. J. R. Strecker, W. D. Lehmann, A. S. Wolf, K. Müsch: Suppression of the maternal and 
fetal pituitary-adrenocortical axis by administration of beta-methasone during 
pregnancy 33 
31. W G Sippell, P. Gaede, 0. Fleischmann, F. Bidlingmaier, D. Knorr, D. Troelle: Plasma 
concentrations of eight unconjugated steroids in mother and fetoplacental unit at term 
delivery *) 34 
32. G Reck, U. Noss, M. Breckwoldt: Circadian rhythm of free estradiol in relation to 
adrenal function during late pregnancy *) 35 
33. W. D. Lehmann, Ch. Lauritzen: Clinical and biochemical studies in three pregnancies 
with placenta] sulfatase deficiency 36 
34. Κ. M. Pirke, M. Geiss, H. J. Vogt: In vitro and in vivo studies on Leydig cell function 
in old rats 37 
35. B. Schenck, F. Neumann: Dissociation between different actions of androgens . . . . 38 
36. R. Ghraf Η-J. Deutsch, Ε. R. Lax, H. Schriefers: Androgen-induced "super/induction" 
of estrogen-dependent 3a-hydroxysteroid dehydrogenase activity in rat kidney cytosol 39 
37. W. Elger, K. Petzoldt: Two chance observations: Inhibition of fertilization after uterine 
insemination and destruction of the uterine surface and glandular epithelium by 
treatment with 18-acetoxy-D-norgestrel in rabbits *) 40 
38. E. R. Lax, E. Kreuzfelder, R. Ghraf, H. Schriefers: The influence of estradiol and 
antiestrogens on hepatic microsomal 3/?-hydroxysteroid dehydrogenase activity in rats 41 
39. M. Schwenk, V Lopez del Pino, Η. M. Bolt: Metabolism and disposition of 17a-
ethinylestradiol and estrone sulfate in isolated rat liver cells *) 42 
40. H. Bojar, W. Staib: Estrogen receptors in rat liver: molecular characteristics, sex 
differences, changes during estrous cycle, translocation by isolated hepatocytes *) . . 43 
41. J. Sandow, W v. Rechenberg, Β. Schölkens, U. Weithmann: Luteolytic activity of a 
synthetic prostaglandin 45 
42. S. Chari, E. Daume, C. Sturm, C. R. N. Hopkinson: Inhibin-like activity in human 
follicular fluid and its characterization *) 46 
43. W. Saeger, H. Mitschke: Morphology of adrenal and ovarian tumors with androgen 
excess *) 47 
V I I I 
Page 
Hormone-Dependent Osteopathies 
44. W. Schulz, P. Spiegel, G. Delling: Effect of 1,25 ( O H ) 2 D 3 on secondary hyperparathyroid­
ism in renal bone disease 48 
45. E. Leicht, G. Biro, Η. Baumhöfener, Chr. Blum: Medium-term effects of low doses of 
1,25-dihydroxy-vitamin D in patients with renal osteopathy 49 
46. R. Hehrmann, A. J. Coburg, P. Neuhaus, G Tidow, J. Thiele: Renal hyperparathyroidism: 
Effect of parathyroidectomy with autotransplantation and of kidney transplantation 
on serum PTH 50 
47. E. Manzke, D. J. Baylink, G P. Vose: Bone density, nondialyzable urinary hydroxy-
proline, serum 25-hydroxy-vitamin D and serum parathyroid hormone during 
fluoride therapy 51 
48. H. U. Schweikert, W. Rulf N. Niederle, Η. Ε. Schaefer: Dihydrotestosterone formation 
in normal and osteoporotic human bone 52 
49. J. Bommer, B. Krempien, E. Ritz, R. Schneider: The influence of thyroxine on 
endosteal cell surface morphology 53 
50. L . Gozariu, E. Barabas: Effect of parathormone and calcitonin on calcium uptake in 
tooth germs *) 53 
51. R. Ziegler, G. Holz, W. Streibl, F. Raue: Nasal application of calcitonin in Paget's 
disease of bone 54 
52. Κ. H. Usadel, U. Schwedes, H. Minne, I . Klempa, J. Vlachyannis, H. P. Fortmeyer, 
K. Schößling: Transplantation of human parathyroid adenoma and carcinoma in 
nude mice 55 
Gastrointestinal Hormones 
53. Ph. U. Heitz, J. M. Polak, G Klöppel, S. R. Bloom, A. G. E. Pearse: Multiple hormone 
producing pancreatic endocrine tumors 56 
54. G. Klöppel, G Delling, A. Knipper, Ph. U. Heitz: Immunocytochemical mapping of 
pancreatic Apudomas in multiple endocrine adenomatosis with primary hyperparathy-
roidism 57 
55. H. W. Börger, Α. Schafmayer, N. J. Smith, M. Werner, H. D. Becker: The influence of 
selective proximal vagotomy on serum gastrin, serum GIP and serum insulin in 
duodenal ulcer patients 58 
56. H. Laube, R. Ebert, S. Raptis, W Schlegel, Κ. Federlin: GIP, secretin, gastrin and 
pancreozymin in the mucosa of sucrose fed rats 59 
57. B. Simon, P. Czygan, H. Kather, B. Kommerell: Stimulation of human colonic 
adenylate cyclase by prostaglandins and vasoactive intestinal polypeptide 60 
Endocrine Pancreas, Somatostatin 
58. W. Beischer, W. Kerner, L . Keller, B. Beischer: Diabetes therapy and control in 
relation to C-peptide levels 61 
59. W. Kerner, E. F. Pfeiffer, Ch. Herfarth: Application of an artificial endocrine pancreas 
in surgery *) 63 
60. S. Raptis, Ch. Zoupas, V. Maier, W. Beischer, J. Rosenthal: Effect of a somatostatin 
analog on glucoregulatory hormones in man 64 
61. U. Schwedes, P. Althoff, S. Szabo, K. Schöffling: Effect of somatostatin on gastrin 
and gastric acid output in rats with cysteamine-induced duodenal ulcer *) 65 
62. F. Diel, Ε. Schneider: Somatostatin binding complexes *) 66 
63. R. Landgraf, Α. Witte, Μ. Μ. C. Landgraf-Leurs: Kinetics of insulin release from 
perifused islets due to growth hormone, lipotrbpin and adiuretin 67 
64. K. Rücken, F. Kümmerle: The present situation of surgery of the endocrine pancreas 
in West Germany 68 
IX 
Page 
65. R. G. Bretzel, E. Manns, C. Schomber, K. Federlin: The liver as a site for implantation 
of islets of Langerhans in experimental diabetes. Morphologic and metabolic 
observations *) 69 
66. V. Maier, G. Witznick, R- Keller, E. F. Pfeiffer: Insulin-like and glucagon-like 
immunoreactivities in the honeybee (Apis mellifera) *) 69 
Thyroid Gland 
67. P. Stubbe, P. Heidemann: The incidence of goitrous hypothyroidism during neonatal 
screening 70 
68. J. Homoki, U. Loos, G. Rothenbuchner, V. Grimm, W M. Teller: TSH, T 4 , T 3 and reverse 
T 3 serum concentrations in the premature infant during the first month of live . . . . 71 
69. M. Grussendorf M. Hüfner: 3,3'-T2 serum levels during the first days of life and in adults 
after ingestion of high doses of r T 3 , T 3 and T 4 *) - . . . . 72 
70. M. Lammers, Α. von zur Mühlen, U. Döhler: Prenatal thyroxine treatment causes 
permanent impairment of hypothalamo-pituitary-thyroid function in rats 73 
71. R. Ködding, B. Höffken: Thyroxine and its metabolites during treatment with propyl-
thiouracil and mercaptoimidazol 74 
72. W. Waldhäusl, P. Bratusch-Μarrain, P. Novotny, A. Luff, H. Schuster: Secondary 
hyperthyroidism associated with pituitary chromophobe adenoma. Study of TSH 
chemistry and release 75 
73. £. Jentsch, P. Stubbe, M. Droese, P. Heidemann: The incidence of Hashimoto's thyroid­
itis in childhood 76 
74. W Scherbaum, Κ. 0. Rosenau, F. J. Seif: Rheumatoid factors and thyroid antibodies 
in Graves'-Basedow disease 77 
75. Η. Ludwig, G. Schernthaner, E. Richter, N. Zambelis, G. Wick: Thyroglobulin binding 
cells, a diagnostic marker for Hashimoto's thyroiditis *) 78 
76. G. Schernthaner, H. Schleusener, R. Finke, P. Kotulla, H. Ludwig, W. R. Mayr: Thyroid 
stimulating immunoglobulins in HLA-typed patients with ophthalmic Graves' disease, 
thyrotoxicosis and Hashimoto's thyroiditis *) 79 
77. F. J. Seif W. Scherbaum, W. Klingler: Syndrome of elevated thyroid hormone and 
TSH blood levels. A case report 81 
78. V. Loos, F. Konrad, G. Rothenbuchner: ^-hyperthyroidism under the aspects of 
thyroidal hormone secretion and peripheral formation 82 
79. C. C. Wong, K.-D. Döhler: Effects of light-dark changes on serum levels of prolactin, 
TSH, T 3 and T 4 in male rats of different ages *) 83 
80. B. Höffken, R. Ködding, J. Köhrle, R-D. Hesch: Characteristics of 5- and 5'-deiodination 
o f T 4 * ) 85 
81. D. Auf dem Brinke, J. Köhrle: Reexamination of the subcellular localization of T 4 to T 3 
converting enzyme ( T 4 to T 3 deiodase = E) in rat liver 86 
82. M . Hüfner, Μ. Grussendorf: Studies on reverse T 3 degradation in rat liver homogenate *) 87 
Gonadotropins, Gonadal Function 
83. V. Lichtenberg, D. Graesslin, V. G. Pahnke: Quantitation of human serum L H by RIA 
and an in vitro biossay(TPA) after gel chromatography: overestimation by RIA . . . 88 
84. W. Krause, W. Schaeg: The use of staphylococcal protein A for precipitating the antigen-
antibody complex in the hFSH and h L H radioimmunoassay *) 90 
85. R. Baumann, H. Kühl: LH-RH interactions with purified plasma membranes of rat 
anterior pituitary gland *) 91 
86. T. O. F. Wagner: Binding kinetics for the interaction of mono-iodo-GnRH and ovine 
anterior pituitary *) 92 
87. W Krause, 5. Peters: On the correlation of serum levels of FSH, L H and prolactin . . 92 
X 
Page 
88. W Beck, J- L . Hancke, W. Wuttke: Annual rhythm of plasma L H , FSH, prolactin and 
testosterone in male Rhesus monkeys 93 
89. W. D. Hetzel, H. D. Laepple: The effect of combined administration of sulpiride and 
bromocriptine on the hypophyseal-gonadal feedback mechanism in healthy males . . 94 
90. K.-J. Graf, M. Schmidt-Gollwitzer, U. J. Koch, F. Lorenz, J. Hammerstein: Hyperpro-
lactinemia induced by cyproterone acetate in human subjects 96 
91. L. Weißbach, G. Leyendecker, Ch. Stangenberg, Η. U. Schweikert: Partial insensitivity of 
hypothalamic-pituitary centers to sexual steroids in the Reifenstein syndrome . . . . 97 
92. R. Horowski, K.-J. Graf B. Nieuweboer, H. Wendt, P. G Chiodini, A. Liuzzi: Influence of 
depot progestagens on anterior pituitary and adrenocortical hormones 98 
93. N. Parvizi, F. Ellendorff: Differentiated effect of norepinephrine on L H secretion 
after intracerebral microinjections 99 
94. V. G Pahnke, A. Brandt, F. Leidenberger: Gonadal function of male and female rats in 
experimentally induced hypo- and hyperthyroidism 99 
95. D. Schorns, Β. Hoffmann, Κ. Η. Lotthammer, L . Ahlswede: Specific effects of vitamin-A-
unrelated ß-carotin deficiency on fertility parameters in cattle 101 
96. U. Gethmann, P. Ball, R. Knuppen: Effect of 2-hydroxyestrone on gonadotropin secretion 
in the ovariectomized rat *) 102 
97. K. G. Höhn, P. Witte, W. Wuttke: Regional changes in catecholamine (CA) turnover 
and CA-synthetizing enzymes in response to ovariectomy and estradiol *) 103 
98. Ν. M. Qureshi, I . Yousuf S. Naqvi, M. A. Qureshi: Testis specific LDH-X. Studies in a 
reptilian species and in the rat following FSH, L H , testosterone and estrogen admin­
istration *) 104 
Parathormone 
99. H. Jüppner, J. Sraer, R. Ardaillou, H. Ebel, Μ. Ruf, Η. Mohr: ΡΤΗ receptors at different 
sites along the nephron 105 
100. A. A. Bialasiewicz, V. Diehl, H. Jüppner: Binding kinetics of PTH to cultured B-and T-
lymphocytes *) 106 
101. H. Mohr, R.-D. Hesch: Parathormone degrading activity in basal lateral membranes 
of the bovine renal cortex 107 
102. M. Dietel, G. Dorn, Ε. Altenähr: Effect of high and physiological concentrations of 
1,25 DHCC on infrastructure and secretion of human parathyroid adenomas and 
porcine parathyroids 109 
103. M. A. Dambacher, W. Hunziker, W. Born, J. Moran, J. A. Fischer: Circulating forms of 
immunoreactive parathyroid hormone (PTH) in control subjects and in patients with 
primary and secondary hyperparathyroidism 110 
104. H. von Lilienfeld-Toal, A. Edis, C. D. Arnaud: Metabolism of endogenous parathyroid 
hormone (PTH) in hyperparathyroid patients I l l 
105. J. P. Nordmeyer, R. Hehrmann, G Tidow: Primary hyperparathyroidism: increasing 
experience with clinically extraordinary cases 112 
106. G. Biro, E. Leicht: Radioimmunological estimation of human parathyroid hormone: 
comparison of separation techniques *) 112 
107. W. G. Wood, I . Marschner: Comparison of different labelling and separation techniques 
in the production of a stable 1251 bovine parathyrin tracer *) 113 
108. W. G Wood, G. Kuflicki, I . Marschner, P. C. Scriba: Rapid sensitive and reproducible 
assays for human parathyrin *) 116 
109. W. Engelhardt, P. O. Schwüle: Modifications of the Hunter radioiodination of highly 
purified bovine PTH (bPTH) *) 117 
110. F. Roue, R. Ziegler, F. Nobbe, A. Schäfer: Medullary thyroid carcinoma. Localisation 
of metastases by selective venous catheterisation *) 118 
111. J. McK. Halket, B. P. Lisboa: An approach to the recognition and quantitation of 
vitamin D and its metabolites using gas chromatography-mass spectrometry *) . . .120 
X I 
Neurosecretion 
112. A. Weindl, Μ. V. Sofroniev, R. Wetzstein: Immunohistochemical demonstration of 
secretory neurons in the brain of the North American opossum (Didelphys virginiana) 
and the mole (Talpa europea) 121 
113. /. Felsl, M . Gottsmann, Τ. Eversmann, W. Jehle, E. Uhlich: Influence of various stress 
situations on vasopressin secretion in man 122 
114. R. Lorenz, Ε. Uhlich: Vasopressin release from perifused isolated rat hypothalamus-
hypophysis preparations 123 
115. F. Ellendorff, Μ. L . Forsling, N. Parvizi, N. Taverne, D. Smidt: Prostaglandin-induced 
oxytocin secretion in the pig 125 
116. T. Heinzeller, H. Vogel: An estimation of the release of neurosecretory material by the 
corpora cardiaca in the honeybee *) 125 
Paraneoplastic Hormone Production 
117. C. J. M. Lips, J. A. van der Donk, R. Η. van Dam, W. H. L . Hackeng, J. van der Sluys Veer : 
A common precursor molecule as origin of the ectopic hormone-producing tumor 
syndrome 127 
118. J. A. van der Donk, C. J. M. Lips, R. H. van Dam, W. H. L . Hackeng, J. van der Sluys Veer : 
A new method to synthesize human peptide hormone precursors *) 128 
119. H. Minne, W Streibl, S. Stanislaus, C. D. Arnaud: Paraneoplastic parathyroid hormone 
(PTH) secretion by the transplantable Walker carcinosarcoma 256 of the rat . . . .129 
120. K. Mann, R. Lamerz, G. Staehler, H. J. Karl: Tumor markers HCG-ß and AFP in 
patients with testicular seminoma and teratocarcinoma 130 
121. Η. K. Kley, W. Berges, Η. L . Krüskemper: Diagnosis of bronchial carcinoma with ectopic 
ACTH production 130 
Kidney, Varia 
122. Β. Α. Schölkens: Intranasal administration of an angiotensin I I antagonist 131 
123. M. Schöneshöfer, G. Schutze, W. Oelkers: Effects of prolonged infusion of angiotension 
I I on eight serum corticosteroids in man 132 
124. H. J, Kramer, Τ Moch, L , v. Sicherer: Effects of inhibition of the kinin system on renal 
hemodynamics and salt and water excretion in acutely saline-loaded rats 133 
125. K. Lichtwald, Κ.-Η. Kohl, D. Haack, Th. Connolly, P. Vecsei, I . Vince: Separation of 
T H - A L D like radioimmunoactive, less polar materials from human urine 135 
Steroid Receptors, Carcinomas 
126. P. W Jungblut, Ε. Kallweit, W Sierralta, A. J. Truitt, R. K. Wagner: Estradiol and 
receptor content of uterine nuclei from ovariectomized and ovariectomized/adrenal-
ectomized pigs 136 
127. B. J. Jungblut: Sequential extraction of various forms of estradiol receptor 137 
128. R. K. Wagner, Κ. H. Schulze: Clinical relevance of androgen receptor content in human 
prostate carcinoma 139 
129. M. Krieg, I . Grobe, Ε. Altenähr, Κ. D. Voigt: Differences in androgen binding and 
metabolism between human prostatic carcinoma and human benign prostatic hyper­
trophy 140 
130. R.-Th. Michel, G. Basiert, Η. P. Fortmeyer, D. Nord, Η. Schmidt-Μatthiesen: Effect of 
ablative, additive and anti-estrogen (Tamoxifen) treatment on the tumor growth of 
transplanted human breast cancers in nude mice *) 141 
131. P. Unterburger, D. Engelhardt: Metabolism of testosterone and 5a-dihydrotestosterone 
in normal human endometrium and endometrial carcinoma *) 143 
X I I 
4. Hypersecretion of A C T H , growth hormone and prolactin in a patient with pituitary 
adenoma* 
O. A. M Ü L L E R , R. F I N K , K. V. WERDER, P. C. SCRIBA, Medizinische Klinik Innenstadt der 
Universität München 
Patients with pituitary tumors and hypersecretion of two pituitary hormones have been 
observed. The most common combination seems to be hypersecretion of growth hormone 
(hGH) and prolactin [1 ] . The combination of hypersecretion of other pituitary hormones, 
such as A C T H and hGH [ 2 ] or prolactin (PRL) and TSH [3] is extremely rare. The following 
case report concerns a patient with a pituitary adenoma with hypersecretion of three pituitary 
hormones: hGH, ACTH and PRL. The 45-year old male patient was readmitted to our hospital 
in August 1977 for evaluation of pituitary function. This patient was known to us since 1968 
when he was first admitted to our hospital because of active acromegaly. Before pituitary surgery 
was performed, an acutely manifesting Cushing's syndrome with excessively elevated A C T H -
levels was observed [2 ] . He was therefore first totally adrenalectomized followed by transfrontal 
pituitary surgery. One year later, the Cushing syndrome had disappeared but hGH-levels were 
still elevated. In the following seven years he was lost to follow-up. At readmission he still had 
active acromegaly but no excessive pigmentation. Pituitary function tests revealed elevated 
hGH-levels between 55 and 75 ng/ml, whereas ACTH-levels under substitutional therapy were 
only moderately elevated up to 100pg/ml. PRL-levels were also found to be extremely high, 
ranging from 460 to 600 ng/ml. Gonadotropin and TSH-secretion was blunted, necessitating 
replacement therapy. 
hGH-hypersecretion: The elevated hGH-levels could not be suppressed by an oral glucose 
load which revealed a diabetic carbohydrate tolerance with extremely elevated insulin levels. 
Administration of T R H and GnRH led to a stimulation of hGH, documenting the in-
* Supported by the Deutsche Forschungsgemeinschaft (SFB 51). 
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appropriate regulation of hGH-secretion. Administration of the dopamine agonists 1-Dopa 
(0.5 g) and bromocriptine (2.5 mg) led to a fall from a basal level of 55 to 18 ng/ml (1-Dopa), 
respectively 58 to 12 ng/ml (bromocriptine). Somatostatin (SRIF) inhibited hGH-secretion in 
the same manner. 
ACTH-hypersecretion: ACTH-levels were significantly suppressed after 2.5 mg bromocrip­
tine from a basal level of 86 to 30pg/ml and the administration of SRIF suppressed A C T H 
from 99 to 21 pg/ml. 
Ρ RL-hy per secretion: PRL-levels could not be stimulated by T R H and the administration of 
SRIF led only to a minor fall of PRL from 512 to 420 ng/ml. In contrast, administration of the 
dopamine agonists led to a significant fall of PRL from 501 ng/ml to 294 ng/ml (1-Dopa), 
respectively from 442 to 100 ng/ml (bromocriptine). 
The anatomical evaluation of the pituitary by lateral skull X-ray and computer tomog­
raphy revealed a large pituitary tumor with suprasellar extension. The tumor histology from 
1969 showed a pituitary adenoma which could not be differentiated by classical staining but 
showed evidence of necrosis in the adenomatous tissue which might explain the only 
moderately elevated ACTH-levels after bilateral adrenalectomy (autohypophysectomy). 
Despite suprasellar extension and active acromegaly the patient refused to be operated 
again and was therefore treated medically with bromocriptine. After 7 weeks of treatment with 
7.5 mg bromocriptine daily, a fall of hGH-levels to 26 and of PRL to 163 ng/ml could be 
observed. The ACTH-levels were not significantly influenced by long-term bromocriptine 
administration. Because hGH- and PRL-levels are not completely normalized, the dosage has 
been raised in the meantime and the patient wil l be eventually irradiated. 
To our knowledge this patient represents the first documented case of topic hypersecretion 
of three pituitary hormones. It is interesting to note that the hormone excess of all three 
hormones can be uniformly inhibited by dopamine agonists. It is tempting to speculate that 
disturbance of hypothalamic dopamine-mediated neurotransmission may be the cause of the 
threefold pituitary hormone excess. 
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